<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) is one of the most common causes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related mortality </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="26666">Short-chain fatty acids</z:chebi> secreted by dietary propionibacteria from the intestine, such as <z:chebi fb="49" ids="30089,47622">acetate</z:chebi>, induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells and may therefore be relevant in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> prevention and therapy </plain></SENT>
<SENT sid="2" pm="."><plain>We previously reported that <z:chebi fb="22" ids="15366">acetic acid</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in Saccharomyces cerevisiae cells involves partial vacuole permeabilization and release of Pep4p, the yeast cathepsin D (CatD), which has a protective role in this process </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, lysosomes have emerged as key players in <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through selective lysosomal membrane permeabilization (LMP) and release of cathepsins </plain></SENT>
<SENT sid="4" pm="."><plain>However, the role of CatD in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> survival is controversial and has not been assessed in response to <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>We aimed to ascertain whether LMP and CatD are involved in <z:chebi fb="49" ids="30089,47622">acetate</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>We showed that <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> per se inhibits proliferation and induces <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>More importantly, we uncovered that <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> triggers LMP and CatD release to the cytosol </plain></SENT>
<SENT sid="8" pm="."><plain>Pepstatin A (a CatD inhibitor) but not E64d (a cathepsin B and L inhibitor) increased <z:chebi fb="49" ids="30089,47622">acetate</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells, suggesting that CatD has a protective role in this process </plain></SENT>
<SENT sid="9" pm="."><plain>Our data indicate that <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> induces LMP and subsequent release of CatD in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells undergoing <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and suggest exploiting novel strategies using <z:chebi fb="49" ids="30089,47622">acetate</z:chebi> as a prevention/therapeutic agent in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, through simultaneous treatment with CatD inhibitors </plain></SENT>
</text></document>